2.53
price down icon4.89%   -0.13
after-market Dopo l'orario di chiusura: 2.53
loading
Precedente Chiudi:
$2.66
Aprire:
$2.65
Volume 24 ore:
892.24K
Relative Volume:
0.70
Capitalizzazione di mercato:
$277.57M
Reddito:
-
Utile/perdita netta:
$-134.24M
Rapporto P/E:
-1.4294
EPS:
-1.77
Flusso di cassa netto:
$-121.34M
1 W Prestazione:
-5.60%
1M Prestazione:
-15.95%
6M Prestazione:
-64.86%
1 anno Prestazione:
-56.15%
Intervallo 1D:
Value
$2.42
$2.69
Intervallo di 1 settimana:
Value
$2.42
$2.825
Portata 52W:
Value
$2.39
$8.40

Annexon Inc Stock (ANNX) Company Profile

Name
Nome
Annexon Inc
Name
Telefono
(650)-822-5500
Name
Indirizzo
1400 SIERRA POINT PARKWAY, BRISBANE
Name
Dipendente
100
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
ANNX's Discussions on Twitter

Confronta ANNX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ANNX
Annexon Inc
2.53 277.57M 0 -134.24M -121.34M -1.77
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
502.92 129.14B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
680.61 74.41B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
581.21 35.31B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
241.75 31.30B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
254.57 27.35B 3.32B -860.46M -1.04B -8.32

Annexon Inc Stock (ANNX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-03-01 Aggiornamento JP Morgan Neutral → Overweight
2023-12-21 Aggiornamento BofA Securities Neutral → Buy
2023-10-30 Iniziato Wells Fargo Overweight
2023-05-26 Downgrade BofA Securities Buy → Neutral
2023-05-25 Downgrade JP Morgan Overweight → Neutral
2022-09-16 Iniziato Jefferies Buy
2022-09-09 Iniziato BTIG Research Buy
2021-11-30 Iniziato H.C. Wainwright Buy
2021-09-23 Iniziato Cantor Fitzgerald Overweight
2021-01-26 Iniziato Needham Buy
2020-08-18 Iniziato BofA Securities Buy
2020-08-18 Iniziato Cowen Outperform
2020-08-18 Iniziato JP Morgan Overweight
Mostra tutto

Annexon Inc Borsa (ANNX) Ultime notizie

pulisher
Mar 13, 2025

Annexon: Despite Major Catalysts, Stock Is Trading Almost At Cash (NASDAQ:ANNX) - Seeking Alpha

Mar 13, 2025
pulisher
Mar 13, 2025

Annexon, Inc. (NASDAQ:ANNX) Given Average Rating of “Buy” by Analysts - Defense World

Mar 13, 2025
pulisher
Mar 08, 2025

Rhumbline Advisers Purchases 5,854 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Q1 Earnings Forecast for Annexon Issued By HC Wainwright - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Annexon Biosciences: Promising Developments and Strategic Milestones Justify Buy Rating - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Analysts Set Expectations for Annexon FY2025 Earnings - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

Q2 Earnings Estimate for Annexon Issued By HC Wainwright - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

New York State Common Retirement Fund Purchases 20,311 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Potential Price Increase for Annexon Inc (ANNX) After Recent Insider Activity - Knox Daily

Mar 05, 2025
pulisher
Mar 05, 2025

Annexon stock price target cut to $20 at H.C. Wainwright By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

Annexon (NASDAQ:ANNX) Given “Buy” Rating at Needham & Company LLC - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Gaining Ground: Annexon Inc (ANNX) Closes Lower at 2.39, Down -9.47 - The Dwinnex

Mar 04, 2025
pulisher
Mar 04, 2025

Promising Developments in Annexon Biosciences’ Pipeline Drive Buy Rating - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Annexon Biosciences Reports Strong Progress in 2024 - MSN

Mar 04, 2025
pulisher
Mar 03, 2025

Annexon Reports Fourth Quarter and Year-End 2024 Financial Results, Portfolio Progress and Key Anticipated Milestones - The Manila Times

Mar 03, 2025
pulisher
Mar 03, 2025

Annexon reports Q4 EPS (33c), consensus (29c) - TipRanks

Mar 03, 2025
pulisher
Mar 03, 2025

Annexon Reports Fourth Quarter and Year-End 2024 Financial - GlobeNewswire

Mar 03, 2025
pulisher
Mar 03, 2025

Can Annexon's $312M War Chest Fuel Its Breakthrough Treatments Through 2026? - StockTitan

Mar 03, 2025
pulisher
Feb 26, 2025

Annexon stock hits 52-week low at $2.63 amid market challenges - Investing.com Australia

Feb 26, 2025
pulisher
Feb 26, 2025

Annexon Biosciences to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewswire

Feb 26, 2025
pulisher
Feb 26, 2025

What Will Annexon Reveal at the TD Cowen Healthcare Conference Next Week? - StockTitan

Feb 26, 2025
pulisher
Feb 25, 2025

Annexon stock hits 52-week low at $2.63 amid market challenges By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 22, 2025

Annexon stock hits 52-week low at $3.04 amid market challenges - MSN

Feb 22, 2025
pulisher
Feb 22, 2025

Annexon, Inc. (NASDAQ:ANNX) CEO Sells $14,811.95 in Stock - MarketBeat

Feb 22, 2025
pulisher
Feb 21, 2025

Annexon executive sells shares worth $16,379 By Investing.com - Investing.com South Africa

Feb 21, 2025
pulisher
Feb 21, 2025

Annexon EVP Ted Yednock sells $24,283 in stock - Investing.com India

Feb 21, 2025
pulisher
Feb 21, 2025

Annexon chief medical officer sells $16,342 in common stock By Investing.com - Investing.com South Africa

Feb 21, 2025
pulisher
Feb 20, 2025

Annexon chief medical officer sells $16,342 in common stock - Investing.com

Feb 20, 2025
pulisher
Feb 20, 2025

Annexon chief business officer sells $19,523 in company stock By Investing.com - Investing.com Australia

Feb 20, 2025
pulisher
Feb 20, 2025

Annexon executive sells shares worth $16,379 - Investing.com

Feb 20, 2025
pulisher
Feb 20, 2025

Annexon chief business officer sells $19,523 in company stock - Investing.com

Feb 20, 2025
pulisher
Feb 20, 2025

Annexon CFO Jennifer Lew sells shares worth $20,183 By Investing.com - Investing.com South Africa

Feb 20, 2025
pulisher
Feb 20, 2025

Annexon CFO Jennifer Lew sells shares worth $20,183 - Investing.com

Feb 20, 2025
pulisher
Feb 20, 2025

Annexon CFO Jennifer Lew Sells Shares to Cover Tax Obligations - TradingView

Feb 20, 2025
pulisher
Feb 20, 2025

Annexon, Inc. (NASDAQ:ANNX) Short Interest Update - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Annexon, Inc. (NASDAQ:ANNX) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Feb 20, 2025
pulisher
Feb 19, 2025

Annexon EVP sells $4,260 in stock to cover tax obligations - Investing.com India

Feb 19, 2025
pulisher
Feb 18, 2025

Annexon EVP sells $4,260 in stock to cover tax obligations By Investing.com - Investing.com Canada

Feb 18, 2025
pulisher
Feb 18, 2025

Annexon EVP Ted Yednock sells $5,331 in stock By Investing.com - Investing.com Canada

Feb 18, 2025
pulisher
Feb 18, 2025

Annexon CFO Jennifer Lew sells $5,322 in stock By Investing.com - Investing.com South Africa

Feb 18, 2025
pulisher
Feb 18, 2025

Annexon EVP Ted Yednock sells $5,331 in stock - Investing.com

Feb 18, 2025
pulisher
Feb 18, 2025

Annexon CFO Jennifer Lew sells $5,322 in stock - Investing.com

Feb 18, 2025
pulisher
Feb 18, 2025

Annexon CEO Love Douglas sells $14,811 in stock - Investing.com

Feb 18, 2025
pulisher
Feb 18, 2025

Annexon CEO Love Douglas sells $14,811 in stock By Investing.com - Investing.com South Africa

Feb 18, 2025
pulisher
Feb 18, 2025

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Feb 18, 2025

Annexon Inc Azioni (ANNX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$75.07
price up icon 1.39%
$305.39
price down icon 0.55%
$19.19
price down icon 3.62%
$32.68
price down icon 0.52%
$97.47
price down icon 2.84%
biotechnology ONC
$254.57
price up icon 1.89%
Capitalizzazione:     |  Volume (24 ore):